Scholarlink

Purpose <p>Molecular typing can identify relationships between <i>M. genitalium</i> strains and antimicrobial resistance and demographic data. We examined the association of <i>mgpB</i> sequence types (STs) with sex/sexual orientation, antimicrobial resistance and geographical location for <i>M. genitalium</i> in Australia.</p> Methods <p>Sequence data derived from previous studies in Victoria and Queensland were obtained from 170 <i>M. genitalium</i> samples for the <i>mgpB</i>, 23&#xa0;S rRNA, and <i>parC</i> genes. An additional 55 <i>M. genitalium</i> samples from Victoria were sequenced for the same three genes in this study. A combined data set of 225 samples collected between 2017 and 2019 were examined for associations between <i>mgpB</i> ST and (i) sex/sexual orientation, (ii) macrolide and fluoroquinolone resistance, and (iii) geographical location using chi-square test.</p> Results <p>Overall, 66 <i>mgpB</i> STs were identified; the most common were ST-7 (17.9%), ST-4 (11.6%), ST-105 (11.6%), and ST-2 (5.4%). There was a strong association between ST and sex/sexual orientation; ST-4 and ST-105 were most common among men-who-have-sex-with-men (<i>p</i> &lt; 0.0001) while ST-7 among women (<i>p</i> &lt; 0.0001). There was a strong association between ST and macrolide resistance (<i>p</i> = 0.0028). Fluoroquinolone resistance was less common (28.0%) and did not differ by STs (<i>p</i> = 0.20). There was no association between ST and geographic location (<i>p</i> = 0.056).</p> Conclusion <p>In this Australian study, four <i>mgpB</i> STs were common and were strongly associated with sex/sexual orientation and macrolide resistance. This relationship was not seen for fluoroquinolone resistance nor geographic location. These findings highlight the sporadic nature of resistance, indicating a need for effective treatment approaches combined with routine antimicrobial resistance surveillance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Diversity of Mycoplasma genitalium strains in Australia: relationship with sexual networks and antimicrobial resistance

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月3日

查看全文
  • Teck-Phui Chua,
  • Jennifer A. Danielewski,
  • Emma L. Sweeney,
  • Erica L. Plummer,
  • Catriona S. Bradshaw,
  • David M. Whiley,
  • Dorothy A. Machalek,
  • Suzanne M. Garland,
  • Gerald L. Murray

摘要

Purpose

Molecular typing can identify relationships between M. genitalium strains and antimicrobial resistance and demographic data. We examined the association of mgpB sequence types (STs) with sex/sexual orientation, antimicrobial resistance and geographical location for M. genitalium in Australia.

Methods

Sequence data derived from previous studies in Victoria and Queensland were obtained from 170 M. genitalium samples for the mgpB, 23 S rRNA, and parC genes. An additional 55 M. genitalium samples from Victoria were sequenced for the same three genes in this study. A combined data set of 225 samples collected between 2017 and 2019 were examined for associations between mgpB ST and (i) sex/sexual orientation, (ii) macrolide and fluoroquinolone resistance, and (iii) geographical location using chi-square test.

Results

Overall, 66 mgpB STs were identified; the most common were ST-7 (17.9%), ST-4 (11.6%), ST-105 (11.6%), and ST-2 (5.4%). There was a strong association between ST and sex/sexual orientation; ST-4 and ST-105 were most common among men-who-have-sex-with-men (p < 0.0001) while ST-7 among women (p < 0.0001). There was a strong association between ST and macrolide resistance (p = 0.0028). Fluoroquinolone resistance was less common (28.0%) and did not differ by STs (p = 0.20). There was no association between ST and geographic location (p = 0.056).

Conclusion

In this Australian study, four mgpB STs were common and were strongly associated with sex/sexual orientation and macrolide resistance. This relationship was not seen for fluoroquinolone resistance nor geographic location. These findings highlight the sporadic nature of resistance, indicating a need for effective treatment approaches combined with routine antimicrobial resistance surveillance.